NexImmune Stock (NASDAQ: NEXI) stock price, news, charts, stock research, profile.
Open | $2.66 |
Close | $2.76 |
Volume / Avg. | 6.10K / 19.64K |
Day Range | 2.59 - 2.77 |
52 Wk Range | 1.25 - 28.69 |
Market Cap | $3.78M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 1.35% |
Days to Cover | 1.89 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NexImmune (NASDAQ:NEXI) through any online brokerage.
Other companies in NexImmune’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Alzamend Neuro (NASDAQ:ALZN), Entero Therapeutics (NASDAQ:ENTO), Genprex (NASDAQ:GNPX) and Portage Biotech (NASDAQ:PRTG).
There is no analysis for NexImmune.
NexImmune has a consensus price target of $1.75.
The stock price for NexImmune (NASDAQ: NEXI) is $2.7599 last updated June 28, 2024 at 3:57 PM EDT.
There are no upcoming dividends for NexImmune.
NexImmune’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for NexImmune.
NexImmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.